Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.35)

# 2,561

Out of 5,115 analysts

3

Total ratings

66.67%

Success rate

17.14%

Average return

Main Sectors:

Top Industries:

Health Information Services Drug Manufacturers - Specialty & Generic

Stocks Rated by Matthew Hewitt

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CERT Certara	Initiates: Buy	$16	$8.91	+79.57%	1	Sep 29, 2025
	LFCR Lifecore Biomedical	Maintains: Buy	$8 → $10	$8.25	+21.21%	2	Nov 22, 2024

Certara

Sep 29, 2025

Initiates: Buy

Price Target: $16

Current: $8.91

Upside: +79.57%

Lifecore Biomedical

Nov 22, 2024

Maintains: Buy

Price Target: $8 → $10

Current: $8.25

Upside: +21.21%